BIOLASE (NASDAQ:BIOL) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of BIOLASE (NASDAQ:BIOL) in a report released on Wednesday. The firm issued a sell rating on the medical technology company’s stock.

BIOLASE Price Performance

Shares of NASDAQ:BIOL opened at $0.01 on Wednesday. The business has a fifty day moving average price of $0.01 and a 200-day moving average price of $0.01. The company has a market capitalization of $273,937.40, a PE ratio of 0.00 and a beta of 0.67. BIOLASE has a 1-year low of $0.02 and a 1-year high of $1.94.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.